Clinical translation remains limited by insufficient specificity, tumor heterogeneity, complex crosstalk among RNA modifications, potential toxicity, and delivery barriers, so future studies integrating RNA modification mapping with single-cell, spatial, and multi-omics technologies will be essential to define cell-typ...
Yan-Ni Ma, Wen-Zhi Deng, Xiu-Lin Jiang et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.